DK1161452T3 - Kovalent forbundne insulindimerer - Google Patents

Kovalent forbundne insulindimerer

Info

Publication number
DK1161452T3
DK1161452T3 DK00909247T DK00909247T DK1161452T3 DK 1161452 T3 DK1161452 T3 DK 1161452T3 DK 00909247 T DK00909247 T DK 00909247T DK 00909247 T DK00909247 T DK 00909247T DK 1161452 T3 DK1161452 T3 DK 1161452T3
Authority
DK
Denmark
Prior art keywords
covalently linked
insulin dimers
linked insulin
insulin analogue
dimers
Prior art date
Application number
DK00909247T
Other languages
Danish (da)
English (en)
Inventor
Hartwig Hoecker
Dietrich Brandenburg
Chantalle Havenith
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1161452T3 publication Critical patent/DK1161452T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
DK00909247T 1999-02-24 2000-02-24 Kovalent forbundne insulindimerer DK1161452T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908041A DE19908041A1 (de) 1999-02-24 1999-02-24 Kovalent verbrückte Insulindimere
PCT/EP2000/001530 WO2000050456A2 (de) 1999-02-24 2000-02-24 Kovalent verbrückte insulindimere

Publications (1)

Publication Number Publication Date
DK1161452T3 true DK1161452T3 (da) 2009-08-17

Family

ID=7898750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00909247T DK1161452T3 (da) 1999-02-24 2000-02-24 Kovalent forbundne insulindimerer

Country Status (16)

Country Link
US (1) US6908897B2 (es)
EP (1) EP1161452B1 (es)
JP (1) JP4519324B2 (es)
KR (1) KR100658961B1 (es)
CN (1) CN1200949C (es)
AT (1) ATE428729T1 (es)
AU (1) AU765076B2 (es)
CA (1) CA2363639C (es)
CY (1) CY1109241T1 (es)
DE (2) DE19908041A1 (es)
DK (1) DK1161452T3 (es)
ES (1) ES2324093T3 (es)
HK (1) HK1042710B (es)
PT (1) PT1161452E (es)
WO (1) WO2000050456A2 (es)
ZA (1) ZA200106971B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067969A2 (en) * 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CA2580313C (en) 2004-07-19 2016-03-15 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
CN101062948B (zh) * 2006-04-29 2010-05-12 上海生物泰生命科学研究有限公司 单体速效胰岛素及其制法和用途
CA2652989A1 (en) * 2006-06-08 2007-12-13 Diabecore Medical Inc. Derivatized insulin oligomers
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
CN101983066B (zh) 2008-01-30 2016-06-29 印第安那大学科技研究公司 基于酯的胰岛素前药
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
KR20110110174A (ko) 2008-12-19 2011-10-06 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 아미드 기반 글루카곤 슈퍼패밀리 펩티드 프로드럭
US8697632B2 (en) 2008-12-19 2014-04-15 Indiana University Research And Technology Corporation Amide based insulin prodrugs
CA2747490C (en) 2008-12-19 2017-02-14 Indiana University Research And Technology Corporation Insulin analogs
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
US9707176B2 (en) 2009-11-13 2017-07-18 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
EP2582719B1 (en) 2010-06-16 2016-08-10 Indiana University Research and Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
CA2803164C (en) 2010-06-24 2018-08-21 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN104114183A (zh) 2011-12-20 2014-10-22 印第安纳大学研究及科技有限公司 用于治疗糖尿病的基于ctp的胰岛素类似物
AU2013323669B2 (en) 2012-09-26 2018-03-01 Indiana University Research And Technology Corporation Insulin analog dimers
RU2678134C2 (ru) 2013-03-14 2019-01-23 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Конъюгаты инсулин-инкретин
US10232020B2 (en) 2014-09-24 2019-03-19 Indiana University Research And Technology Corporation Incretin-insulin conjugates
EP3197912B1 (en) 2014-09-24 2023-01-04 Indiana University Research & Technology Corporation Lipidated amide-based insulin prodrugs
ES2946247T3 (es) * 2014-11-21 2023-07-14 Merck Sharp & Dohme Llc Agonistas parciales del receptor de insulina
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US11058775B2 (en) 2016-04-26 2021-07-13 Merck Sharp & Dohme Corp. Insulin dimer-incretin conjugates
EP3922260A3 (en) 2016-05-24 2022-06-15 Merck Sharp & Dohme Corp. Insulin receptor partial agonists and glp-1 analogues
EP3463413A4 (en) 2016-05-25 2020-03-04 Merck Sharp & Dohme Corp. PARTIAL INSULIN RECEPTOR AGONISTS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues

Also Published As

Publication number Publication date
DE50015623D1 (de) 2009-05-28
AU765076B2 (en) 2003-09-11
KR100658961B1 (ko) 2006-12-21
ATE428729T1 (de) 2009-05-15
EP1161452B1 (de) 2009-04-15
PT1161452E (pt) 2009-07-08
JP2003525864A (ja) 2003-09-02
HK1042710B (zh) 2006-01-13
DE19908041A1 (de) 2000-08-31
CA2363639C (en) 2010-04-13
JP4519324B2 (ja) 2010-08-04
CN1200949C (zh) 2005-05-11
WO2000050456A3 (de) 2000-12-07
US6908897B2 (en) 2005-06-21
EP1161452A2 (de) 2001-12-12
CN1341122A (zh) 2002-03-20
HK1042710A1 (en) 2002-08-23
US20020160938A1 (en) 2002-10-31
KR20010103772A (ko) 2001-11-23
CA2363639A1 (en) 2000-08-31
ZA200106971B (en) 2003-01-29
CY1109241T1 (el) 2014-07-02
AU3160100A (en) 2000-09-14
WO2000050456A2 (de) 2000-08-31
ES2324093T3 (es) 2009-07-30

Similar Documents

Publication Publication Date Title
DK1161452T3 (da) Kovalent forbundne insulindimerer
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
NO20020348L (no) Peptid acceptor ligeringsmetoder
DK1200418T3 (da) Nematodicide trifluorbutener
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
NL1000566C2 (nl) Complex van een analoog van menselijk insuline, alsmede een dergelijk complex omvattende formulering.
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
SE9904505D0 (sv) Novel compounds
NO970210L (no) Heteroatomholdige cyklopentanopyridyl-oksazolidinoner
SE9502168L (sv) Insulinanalog-kompositioner
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
SE9704546D0 (sv) Novel compounds
IL150981A0 (en) Kahalalide derivatives and pharmaceutical compositions containing the same
ATE219061T1 (de) Huperzin a analoge verbindungen
DE69027472D1 (de) Arylsubstituierte Rhodaninderivate
GB9907571D0 (en) Compounds
DK0487562T3 (da) Farmaceutiske sammensætninger
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DE60038735D1 (de) Pseudomycin analoge
WO2003105762A3 (en) METHOD OF TREATING DISEASES WITH RADIUM-225